Similar articles

• Impact of automation on the quantitation of low molecular weight markers of hemostatic defects.

  Fareed J, Walenga JM, Bick RL, Bermes EJ Jr, Messmore HL Jr. Fareed J, et al. Semin Thromb Hemost. 1983 Oct;9(4):355-79. Semin Thromb Hemost. 1983. PMID: 6229030 Review.
• Plasmatic markers of haemostatic system activation in patients with solid neoplasms.

  Sagripanti A, Carpi A, Ferdeghini M, Baicchi U, Grassi B. Sagripanti A, et al. J Nucl Med Allied Sci. 1990 Oct-Dec;34(4):321-32. J Nucl Med Allied Sci. 1990. PMID: 2151044 Review. No abstract available.
• Increased intravascular coagulation associated with pregnancy.

  Gerbasi FR, Bottoms S, Farag A, Mammen E. Gerbasi FR, et al. Obstet Gynecol. 1990 Mar;75(3 Pt 1):385-9. Obstet Gynecol. 1990. PMID: 2137574
• [Molecular marker for hemostasis and thrombosis].

  Fukutake K, Fujimaki M. Fukutake K, et al. Nihon Rinsho. 1989 Apr;47(4):883-90. Nihon Rinsho. 1989. PMID: 2664266 Japanese. No abstract available.
• Newer techniques in the study of hemostatic disorders.

  Pepper DS, Preston FE, Mibashan RS. Pepper DS, et al. Semin Hematol. 1978 Jan;15(1):73-92. Semin Hematol. 1978. PMID: 341329 Review. No abstract available.